Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer. It leverages its immune-enhancing and antiviral platforms to optimize and develop drug candidates to treat ulcerative colitis, Crohn’s disease, rheumatoid arthritis, and other inflammatory diseases (ABX464), HIV (ABX464), and liver cancer (ABX196).